NDC 51688-6485 - A4172 NERVE BLOCK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51688-6485
- Package NDCs from labels
- 51688-6485-2
- Manufacturer
- Smiths Medical ASD, Inc. | Hospira, Inc.
- Effective date
- 2015-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| A4172 NERVE BLOCK - Smiths Medical ASD, Inc. | Hospira, Inc. | Smiths Medical ASD, Inc. | Hospira, Inc. | 2015-03-24 | MEDICAL DEVICE |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| Lidocaine | ACTIVE MOIETY | 98PI200987 | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | A4172 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.